OTC Markets OTCPK - Delayed Quote USD

bioMérieux S.A. (BMXMF)

136.00

0.00

(0.00%)

At close: June 5 at 8:00:00 PM EDT

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance

bioMérieux, a world leader in the field of in vitro diagnostics, announces the U.S. Food and Drug Administration (FDA) 510(k) clearance for VITEK® COMPACT PRO. This innovative system for microorganism identification (ID) and antibiotic susceptibility testing (AST) will benefit clinical laboratories to help diagnose infectious diseases and combat antimicrobial resistance, and industrial laboratories to identify contaminants for ensuring consumer safety.

PR Newswire 2 months ago

BMXMF
0.00%

BMXXY
BioMerieux SA (BMXMF) Full Year 2024 Earnings Call Highlights: Surpassing Growth Targets and ...

BioMerieux SA (BMXMF) reports robust sales growth, improved profitability, and strategic advancements despite market challenges.

GuruFocus.com 3 months ago

BMXXY
bioMérieux Receives Health Canada Approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

bioMérieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This approval marks a significant advancement in how we approach public health and address today's healthcare challenges associated with respiratory infections and sore throats.

CNW Group 3 months ago

BMXMF
0.00%

BMXXY
bioMérieux Launches GENE-UP® TYPER,an Innovative Diagnostic Solution for Food Industries to Rapidly Analyze the Root Causeof Contamination of Listeria monocytogenes

bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of GENE-UP® TYPER, a real-time, cutting-edge PCR solution for rapid pathogen detection root cause analysis in the food industry.

PR Newswire 3 months ago

BMXMF
0.00%

BMXXY
Global In Vitro Diagnostics Leader bioMérieux Celebrates the Opening of the Molecular and Genomic Innovation Center at the Navy Yard in Philadelphia

bioMérieux, a world leader in in vitro diagnostics, celebrates the opening of the company's Molecular and Genomic Innovation Center. The new 32,000 sq. ft. facility is home to the xPRO™ Program, which has rapidly changed the landscape of food safety diagnostic capabilities by partnering directly with industry leaders to address unmet needs to streamline operational efficiencies and further public health. bioMérieux's global leadership team was on-site for the ribbon cutting event, as Philadelphi

PR Newswire 8 months ago

BMXMF
0.00%

BMXXY

Performance Overview

Return	BMXMF	CAC 40 (^FCHI)
YTD	+28.07%	+5.42%
1-Year	+31.08%	-2.77%
3-Year	+35.02%	+22.36%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

bioMérieux S.A. (BMXMF)

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance

BioMerieux SA (BMXMF) Full Year 2024 Earnings Call Highlights: Surpassing Growth Targets and ...

bioMérieux Receives Health Canada Approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

bioMérieux Launches GENE-UP® TYPER,an Innovative Diagnostic Solution for Food Industries to Rapidly Analyze the Root Causeof Contamination of Listeria monocytogenes

Global In Vitro Diagnostics Leader bioMérieux Celebrates the Opening of the Molecular and Genomic Innovation Center at the Navy Yard in Philadelphia

Performance Overview